+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Prostate Cancer Drugs Market Research Reports

Neuroendocrine Prostate Cancer - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Neuroendocrine Prostate Cancer - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Erleada - Drug Insight, 2019 - Product Thumbnail Image

Erleada - Drug Insight, 2019

  • Report
  • July 2019
  • Global
From
Metastatic Prostate Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Metastatic Prostate Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 138 Pages
  • Global
From
Metastatic Castration-Resistant Prostate Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Metastatic Castration-Resistant Prostate Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 138 Pages
  • Global
From
Prostate Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F - Product Thumbnail Image

Prostate Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F

  • Report
  • May 2024
  • 184 Pages
  • Global
From
United States Prostate Cancer Testing Market by Biomarker Type, Application, End-user, Region, Competition Forecast & Opportunities, 2018-2028 - Product Thumbnail Image

United States Prostate Cancer Testing Market by Biomarker Type, Application, End-user, Region, Competition Forecast & Opportunities, 2018-2028

  • Report
  • July 2023
  • 78 Pages
  • United States
From
Benign Prostatic Hyperplasia Treatment Devices Market - Product Thumbnail Image

Benign Prostatic Hyperplasia Treatment Devices Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
Prostate Cancer Therapeutics Market - Product Thumbnail Image

Prostate Cancer Therapeutics Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Prostate Cancer Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Thumbnail Image

Prostate Cancer Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • August 2024
  • 150 Pages
  • Global
From
UAE Prostate Cancer Therapeutics Market, By Region, Competition, Forecast & Opportunities, 2020-2030F - Product Thumbnail Image

UAE Prostate Cancer Therapeutics Market, By Region, Competition, Forecast & Opportunities, 2020-2030F

  • Report
  • January 2025
  • 82 Pages
  • United Arab Emirates United Arab Emirates
From
Japan Prostate Cancer Drugs Market, By Region, Competition, Forecast & Opportunities, 2020-2030F - Product Thumbnail Image

Japan Prostate Cancer Drugs Market, By Region, Competition, Forecast & Opportunities, 2020-2030F

  • Report
  • September 2024
  • 82 Pages
  • Japan
From
Benign Prostatic Hyperplasia Treatment Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Thumbnail Image

Benign Prostatic Hyperplasia Treatment Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • November 2023
  • 183 Pages
  • Global
From
United Kingdom Prostate Cancer Therapeutics Market, Competition, Forecast and Opportunities, 2018-2028 - Product Thumbnail Image

United Kingdom Prostate Cancer Therapeutics Market, Competition, Forecast and Opportunities, 2018-2028

  • Report
  • October 2023
  • 81 Pages
  • United Kingdom
From
Prostate Cancer - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Thumbnail Image

Prostate Cancer - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • July 2024
  • 150 Pages
  • Global
From
Metastatic Hormone Refractory Prostate Cancer - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Metastatic Hormone Refractory Prostate Cancer - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Hormone Sensitive Advanced Prostate Cancer - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Hormone Sensitive Advanced Prostate Cancer - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Hot Flashes in Prostate Cancer - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Hot Flashes in Prostate Cancer - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Castrate-Sensitive Prostate Cancer (CSPC) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Castrate-Sensitive Prostate Cancer (CSPC) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Prostate Cancer - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Prostate Cancer - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Benign prostatic hyperplasia (BPH) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Benign prostatic hyperplasia (BPH) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Loading Indicator

The Prostate Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat prostate cancer. Prostate cancer is the most common cancer in men, and the drugs used to treat it can vary depending on the stage and severity of the disease. Common treatments include hormone therapy, chemotherapy, and radiation therapy. The Prostate Cancer Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Astellas Pharma, Bayer, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. These companies are constantly researching and developing new drugs to treat prostate cancer, as well as improving existing treatments. Show Less Read more